• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人毛囊蠕形螨(西蒙):在正常样本以及接受红霉素或糖皮质激素全身治疗的患者中的发生率。

Demodex folliculorum hominis (Simon): incidence in a normomaterial and in patients under systemic treatment with erythromycin or glucocorticoid.

作者信息

Bøge-Rasmussen T, Christensen J D, Gluud B, Kristensen G, Norn M S

出版信息

Acta Derm Venereol. 1982;62(5):454-6.

PMID:6183907
Abstract

A study was made of 20 cilia and sebum from 20 nasal follicles from each of 86 persons. In a normomaterial aged 20-30 years. Demodex folliculorum was present in the nasal follicles in 25% and in the cilia in 29% of the subjects. This is consistent with the very high incidence we found 10 years ago. Systemic erythromycin treatment did not erradicate the mite, but the incidence decreased in both regions. Systemic glucocorticoid treatment lowered the incidence in the nasal region, whereas the incidence increased in the ciliary region.

摘要

对86人的20个鼻毛囊中的20根纤毛和皮脂进行了研究。在年龄为20至30岁的正常样本中,25%的受试者鼻毛囊中有毛囊蠕形螨,29%的受试者纤毛中有毛囊蠕形螨。这与我们10年前发现的极高发病率一致。全身用红霉素治疗未能根除螨虫,但两个部位的发病率均有所下降。全身用糖皮质激素治疗降低了鼻部的发病率,而睫部的发病率则有所上升。

相似文献

1
Demodex folliculorum hominis (Simon): incidence in a normomaterial and in patients under systemic treatment with erythromycin or glucocorticoid.人毛囊蠕形螨(西蒙):在正常样本以及接受红霉素或糖皮质激素全身治疗的患者中的发生率。
Acta Derm Venereol. 1982;62(5):454-6.
2
Demodex folliculorum and Demodex brevis as a cause of chronic marginal blepharitis.毛囊蠕形螨和皮脂蠕形螨作为慢性睑缘炎的病因
Ann Acad Med Stetin. 2007;53(1):63-7; discussion 67.
3
Cytologic detection of Demodex folliculorum in cases with persisting skin disorders.持续性皮肤疾病病例中毛囊蠕形螨的细胞学检测
Acta Cytol. 2009 Mar-Apr;53(2):183-4.
4
[Demodicidosis in humans as a current problem in dermatology].[人类蠕形螨病作为皮肤病学中的一个当前问题]
Wiad Parazytol. 2005;51(3):253-6.
5
[Incidence of scalp involvement by Demodex folliculorum Simon ectoparasites in a pathologic-anatomic and forensic medicine autopsy sample].[在病理解剖学和法医学尸检样本中毛囊蠕形螨西蒙外寄生虫累及头皮的发生率]
Arch Kriminol. 1994 Sep-Oct;194(3-4):111-8.
6
[Blepharitis due to Demodex: myth or reality?].[蠕形螨引起的睑缘炎:是神话还是现实?]
J Fr Ophtalmol. 1999 May;22(5):525-7.
7
[Demodex folliculorum in the nasal region].[鼻区的毛囊蠕形螨]
Ugeskr Laeger. 1973 Dec 24;135(52):2869-70.
8
Comparison of Demodex folliculorum density in haemodialysis patients with a control group.血液透析患者与对照组毛囊蠕形螨密度的比较。
J Eur Acad Dermatol Venereol. 2007 Apr;21(4):480-3. doi: 10.1111/j.1468-3083.2007.01926.x.
9
Clinical treatment of ocular Demodex folliculorum by systemic ivermectin.系统用伊维菌素治疗眼部蠕形螨。
Am J Ophthalmol. 2011 Jun;151(6):1030-1034.e1. doi: 10.1016/j.ajo.2010.11.024. Epub 2011 Feb 19.
10
Clinical importance of Demodex folliculorum in patients receiving phototherapy.接受光疗患者中毛囊蠕形螨的临床重要性。
Int J Dermatol. 2008 Jan;47(1):72-7. doi: 10.1111/j.1365-4632.2007.03336.x.

引用本文的文献

1
Raising awareness of Demodex mites: a neglected cause of skin disease.提高对蠕形螨的认识:一种被忽视的皮肤病病因。
Infection. 2025 May 3. doi: 10.1007/s15010-025-02521-z.
2
Relationship between surgical rhinoplasty and Demodex infestation: a case-control study.手术隆鼻与蠕形螨感染的关系:病例对照研究。
Turk J Med Sci. 2023 Nov 11;53(6):1738-1743. doi: 10.55730/1300-0144.5743. eCollection 2023.
3
Type 2 Diabetes Mellitus and Infestation: A Cross-Sectional Study in Peruvian Patients.2 型糖尿病与感染:秘鲁患者的横断面研究。
Int J Environ Res Public Health. 2022 Oct 20;19(20):13582. doi: 10.3390/ijerph192013582.
4
Treatment of mites folliculitis with an ornidazole-based sequential therapy: A randomized trial.基于奥硝唑的序贯疗法治疗螨性毛囊炎:一项随机试验。
Medicine (Baltimore). 2016 Jul;95(27):e4173. doi: 10.1097/MD.0000000000004173.
5
Human demodex mite: the versatile mite of dermatological importance.人体蠕形螨:具有重要皮肤病学意义的多功能螨虫。
Indian J Dermatol. 2014 Jan;59(1):60-6. doi: 10.4103/0019-5154.123498.